arrow_back Back to App

Designating November as American Diabetes Month to Boost Awareness and Prevention

The Senate officially designated November 2023 as American Diabetes Month to raise public awareness about this serious chronic condition affecting millions. The resolution aims to encourage early detection, enhance education on prevention and treatment, and highlight the need to address healthcare access barriers. This supports efforts to reduce the high prevalence and massive economic burden ($412.9 billion annually) of diabetes.
Key points
Public Awareness: Focus on increasing education regarding diabetes prevention, treatment options, and recognizing risk factors (e.g., age over 45, overweight, family history).
Healthcare Access: Recognition of the importance of addressing barriers that limit access to necessary healthcare resources for prevention and management, especially in high-risk communities.
Economic Impact: Acknowledgment that diabetes care is significantly more expensive, costing the nation hundreds of billions annually, and that insulin costs are a major concern.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_474
Sponsor: Sen. Shaheen, Jeanne [D-NH]
Process start date: 2023-11-27
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating November 2023 as American Diabetes Month.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_474.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-11-27.

What are the main provisions?

Key points include:

  • Public Awareness: Focus on increasing education regarding diabetes prevention, treatment options, and recognizing risk factors (e.g., age over 45, overweight, family history).
  • Healthcare Access: Recognition of the importance of addressing barriers that limit access to necessary healthcare resources for prevention and management, especially in high-risk communities.
  • Economic Impact: Acknowledgment that diabetes care is significantly more expensive, costing the nation hundreds of billions annually, and that insulin costs are a major concern.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Shaheen, Jeanne [D-NH].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5617; text: CR S5600-5601)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health